Sentinel lymph node biopsy for cutaneous melanoma: Results of 10 years' experience in two regional training hospitals in the Netherlands

International Journal of Clinical Oncology

Volumn 18, Issue 3, 2013, Pages 428-434

  Van Den Broek, Frank J ^a   Sloots, Pim C ^b   De Waard, Jan Willem D ^a   Roumen, Rudi M ^b  

^a Westfries Gasthuis ^*  (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Lymphatic metastasis; Melanoma; Neoplasm staging; Sentinel lymph node biopsy; Skin neoplasms; Survival analysis

Indexed keywords

NANOCOLL TC 99M; NANOCOLLOID ALBUMIN TC 99M; RADIOPHARMACEUTICAL AGENT; SOLCO R; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CUTANEOUS MELANOMA; DATA ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; FALSE NEGATIVE RESULT; FEMALE; HOSPITAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TREATMENT PLANNING; WIDE EXCISION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84879414079     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0399-3     Document Type: Article

References (29)

1. Richtig E, Gerger A, Berghold A et al (2007) Natural history of invasive cutaneous melanoma in Styria, Austria 2001-2003. J Dtsch Dermatol Ges 5(4):293-299
2. Balch CM, Soong SJ, Gershenwald JE et al (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19(16):3622-3634
3. Balch CM, Buzaid AC, Soong SJ et al (2003) New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21(1):43-52
4. Drepper H, Kohler CO, Bastian B et al (1993) Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 72(3):741-749
5. Baas PC, Schraffordt KH, Hoekstra HJ et al (1992) Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg 127(3):281-286
6. Cascinelli N, Morabito A, Santinami M et al (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351(9105):793-796
7. Balch CM, Soong S, Ross MI et al (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7(2):87-97
8. Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392-399
9. Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES et al (2001) The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 91(12):2401-2408
10. Thompson JF, McCarthy WH, Bosch CM et al (1995) Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5(4):255-260
11. van der Veen H, Hoekstra OS, Paul MA et al (1994) Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 81(12):1769-1770
12. McMasters KM, Reintgen DS, Ross MI et al (2001) Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 19(11):2851-2855
13. Mohrle M, Schippert W, Rassner G et al (2004) Is sentinel lymph node biopsy of therapeutic relevance for melanoma? Dermatology 209(1):5-13
14. Thomas JM (2007) Correspondence to the editor. Sentinel-node biopsy in melanoma. N Engl J Med 356(4):418-421
15. Estourgie SH, Nieweg OE, Kroon BB (2004) High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 91(10):1370-1371
16. Thomas JM, Clark MA (2004) Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 30(6):686-691
17. Morton DL, Thompson JF, Cochran AJ et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307-1317
18. Balch CM, Soong SJ, Bartolucci AA et al (1996) Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224(3):255-263
19. Morton DL, Thompson JF, Essner R et al (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230(4):453-463
20. Centraal Beleidsorgaan voor de intercollegiale toetsing. http://www.cbo.nl/Downloads/322/rl-melanoomvdhuid-2005.pdf. Accessed 25 Aug 2008
21. Estourgie SH, Nieweg OE, Valdes Olmos RA et al (2003) Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10(6):681-688
22. Morton DL, Cochran AJ, Thompson JF et al (2005) Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242(3):302-311
23. van Poll D, Thompson JF, Colman MH et al (2005) A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Ann Surg Oncol 12(8):597-608
24. Kang JC, Wanek LA, Essner R et al (2005) Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol 23(21):4764-4770
25. Molenkamp BG, Statius Muller MG, Vuylsteke RJ et al (2005) Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 31(2):211-212
26. Cascinelli N, Belli F, Santinami M et al (2000) Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7(6):469-474
27. Ferrone CR, Panageas KS, Busam K et al (2002) Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 9(7):637-645
28. Gershenwald JE, Thompson W, Mansfield PF et al (1999) Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17(3):976-983
29. Reintgen D, Pendas S, Jakub J et al (2004) National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol 31(3):363-373